Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACTB		ENSG00000075624	"Actin beta"	P60709	7	5526409-5563902	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 22882.9;Pancreatic endocrine cells: 14370.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002621, HPA041264, HPA041271"	Supported					NA	NA		5800000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002621: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (9.80e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	2558.1	1235.8	2143.2	4250.8	2321.0	3598.4	2009.8	2400.1	2776.1	2274.6	2183.3	6581.2	1659.0	5033.9	1630.3	2928.9	2943.6	1772.1	817.6	2355.6	2315.8	1313.6	1759.9	2876.0	4394.2	2654.8	2338.9	1711.5	761.9	838.5	731.4	1817.2	2569.2	2027.1	2338.4	488.2	1470.2	2943.2	465.1	1541.7	2825.9	5736.8	2457.9	3009.5	2869.7	558.3	2483.4	3278.4	1317.9	524.0	4602.3	3720.8	2223.5	3045.4	7791.1	5198.8	5604.1	4658.2	2321.1	3120.3	6654.3	6049.6	4853.2	6209.7	4619.4	8249.5	4361.9	4522.7	4557.0	9445.4	4904.8	4820.3	3279.5	9453.9	4507.4	5324.6	1668.7	3974.3	4579.6	4520.6	3538.8	4733.2	9853.8	4098.5	2786.7	6863.0	1738.0	4128.6	5073.2	3561.3	2189.7	3513.0	6603.4	7531.9	4055.1	13162.1	6813.7	2468.5	3490.8	5658.6	3351.4	3419.7	5904.6	3175.8	1633.1	2746.9	5754.7	5822.1	2400.3	5088.3	5859.7	5314.8	7975.3	10437.4	7019.9	7000.1	8802.8	1902.3	2442.5	5082.1	5772.0	6622.6	12412.7	14674.1	18104.2	29636.6	10647.1	19648.6	8327.7	5139.6	7639.4	9512.9	19292.5	4844.1	5592.0	7894.3	18040.6	6233.1	22870.8	7122.2	11463.2	37406.8	2143.2	2321.0	2400.1	2776.1	2355.6	2315.8	2654.8	2338.9	2569.2	2457.9	2483.4	3045.4	2775.4	1150.6	680.4	142.4	4118.9	5737.0	9776.6	5792.0	3110.2	146.7	1564.0	2047.2	145.3	1080.9	2763.3	2144.5	85.5	3647.7	3989.3	3419.3	2277.4	6508.8	101.3	1422.1	2344.0	2768.4	1451.5	3170.9	129.3	6365.4	12480.2	2958.5	3136.1	2041.6	1539.9	2372.0	2163.5	2590.6	13977.7	269.2	101.3	2006.7	3694.5	7392.0	11420.0	199.7	1766.7	8486.4	2995.4	259.5	22882.9	1654.4	5237.9	116.1	302.2	14370.0	2899.8	2680.3	3040.4	4764.9	4968.2	2149.2	1453.8	146.7	3287.0	1398.2	5423.9	133.8	381.9	4376.1	4722.2	3257.7	5961.7	1688.9	1966.6	6941.4
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934166-93976739	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 522.2;tongue: 157.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	2.9	0.8	0.8	5.6	2.1	0.5	1.5	0.0	1.9	12.0	0.0	66.5	4.0	31.6	0.3	4.0	26.6	0.5	78.5	0.6	0.0	0.5	0.5	3.0	7.4	0.1	0.0	2.9	0.3	0.2	0.2	0.2	0.3	14.4	0.4	0.0	6.6	0.9	522.2	2.3	18.3	1.6	0.0	4.2	17.2	0.4	0.3	0.4	1.2	157.6	3.2	30.4	8.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	12.4	0.0	0.2	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	42.1	8.6	1.7	0.5	2.6	0.5	0.0	0.2	50.8	1.9	2.7	0.3	1.9	1.7	3.8	4.2	0.4	0.2	0.5	0.1	0.0	7.8	0.4	2.3	1.3	0.8	2.1	0.0	1.9	0.6	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.0	0.3	3.3	0.4	0.1	8.4	0.0	0.2	0.2	0.9	51.1	0.0	2.9	0.0	0.0	0.1	3.0	0.0	0.0	1.4	26.4	1.7	0.3	0.5	0.0	2.7	4.7	0.0	0.5	1.9	1.1	2.5	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	0.0	0.3	29.9	0.3	5.3	1.8	1.9	5.8	0.8	2.1	0.0	0.7	0.2	0.0	0.4	10.7	0.1	0.0	0.0	0.4	1.1	0.0	27.6	5.0	0.8	8.4	0.1	0.1	2.9	14.5	0.1	0.1	0.3
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623409-57633239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 61.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.0;Excitatory neurons: 22.0;Horizontal cells: 21.9;Inhibitory neurons: 13.4;Smooth muscle cells: 7.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		35000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	1.9	1.1	26.9	1.9	29.7	0.0	0.7	29.3	61.1	1.3	0.6	2.7	0.5	2.1	2.7	0.7	0.7	1.1	3.3	34.9	21.9	0.8	0.4	0.6	0.6	16.7	11.8	0.3	0.3	0.3	1.7	0.4	20.5	2.6	1.2	4.2	1.8	5.0	9.5	0.6	1.2	2.5	8.1	0.6	0.9	0.7	19.1	0.3	1.2	7.2	1.0	1.2	1.6	29.9	7.5	38.2	18.2	38.7	0.3	0.1	0.4	3.0	11.3	19.0	17.5	2.8	21.9	3.0	47.9	13.2	35.9	3.3	15.3	2.1	5.2	67.4	2.6	1.8	10.1	9.9	0.4	3.1	4.1	0.1	0.9	11.0	0.5	6.7	0.2	11.4	8.7	34.8	2.4	13.5	2.5	0.1	13.0	0.9	7.7	0.1	27.1	8.0	0.1	0.1	34.9	12.3	3.1	1.1	0.4	0.9	7.0	3.3	0.0	22.8	28.1	24.0	26.1	37.0	34.0	2.6	28.9	2.3	45.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.9	29.7	29.3	61.1	34.9	21.9	16.7	11.8	20.5	8.1	19.1	29.9	0.8	0.0	0.0	2.6	0.0	0.4	0.0	0.0	0.0	10.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.0	0.8	0.0	0.0	22.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	21.9	13.4	0.0	0.0	0.0	0.3	0.7	2.8	0.1	3.6	2.8	2.6	0.7	0.0	4.5	2.7	0.5	0.0	3.0	0.0	0.1	0.0	0.2	0.0	2.6	6.6	0.6	7.5	1.6	4.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1 scaffold protein, Cas family member"	P56945	16	75228181-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: AB_2677929"	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavorable (9.11e-5)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	34.7	22.3	3.5	4.2	5.8	0.0	27.9	16.9	6.6	37.7	6.3	34.4	15.8	39.2	2.6	22.5	25.3	9.4	47.1	2.3	7.9	47.3	34.2	38.8	2.1	3.9	1.9	19.7	32.4	5.9	29.5	14.1	2.3	25.6	3.5	1.3	25.5	5.7	93.8	18.2	33.1	3.8	0.0	33.7	44.6	34.3	4.2	0.9	26.8	6.8	1.1	24.9	26.2	15.8	21.8	36.8	17.5	6.0	6.7	6.3	34.1	29.5	17.1	20.9	16.4	46.5	32.1	1.9	38.2	33.3	23.6	18.2	6.1	34.0	6.0	0.1	20.0	0.0	23.7	37.2	16.7	0.1	15.1	19.1	16.3	25.3	12.5	12.3	57.9	0.0	20.0	1.0	12.6	48.9	0.1	1.3	23.4	16.1	24.0	0.8	7.9	8.2	19.1	27.9	21.4	31.5	28.7	6.6	11.2	8.4	15.0	5.4	53.6	34.4	29.5	8.8	44.2	8.0	4.7	0.7	22.2	0.1	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	16.9	6.6	2.3	7.9	3.9	1.9	2.3	0.0	4.2	15.8	30.1	22.4	6.9	9.4	1.2	28.0	59.7	36.8	12.0	26.5	20.3	14.4	22.9	31.5	21.8	22.0	6.2	46.8	0.7	75.7	27.4	51.9	19.0	13.7	27.9	49.2	34.8	0.0	13.1	61.8	25.7	21.1	71.9	22.5	8.9	15.0	46.8	21.0	6.0	13.5	11.7	42.1	12.2	1.4	6.3	26.8	16.4	2.1	32.0	10.3	0.6	12.9	0.0	19.1	31.2	68.5	59.6	33.4	1.4	58.4	57.4	38.9	13.1	6.8	19.7	8.5	38.5	20.6	17.1	12.5	17.6	36.1	2.2	10.9	33.7	62.7
CDR2	"CDR62, Yo"	ENSG00000140743	"Cerebellar degeneration related protein 2"	Q01850	16	22345936-22437165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 70.2;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.4;NK-cells: 2.5;T-cells: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018151, HPA023870"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA018151: AB_1846457, HPA023870: AB_1846459"	"unprognostic (7.89e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.38e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.67e-3)"	19.1	12.0	9.5	19.0	17.7	23.9	14.6	13.6	10.9	18.8	32.0	22.5	28.6	17.8	10.3	12.1	15.9	22.2	14.3	9.8	9.5	25.0	22.9	21.6	25.4	8.6	7.6	14.9	13.9	13.2	21.8	15.0	8.5	20.7	19.3	74.0	15.7	23.1	5.9	10.6	22.1	27.2	5.0	18.7	17.5	62.0	10.5	28.2	49.0	5.6	19.3	29.2	14.0	8.3	38.9	26.8	22.8	24.2	55.2	47.4	23.9	36.4	57.0	36.7	48.4	35.3	25.9	33.3	19.3	62.4	22.2	36.5	49.2	20.8	43.0	26.2	25.1	25.3	29.4	111.0	63.4	27.6	49.6	35.6	18.8	36.2	40.3	46.3	46.2	42.6	25.1	53.3	35.4	28.0	27.8	20.0	32.4	32.3	22.0	40.1	29.4	49.5	45.7	24.8	17.5	12.5	24.8	51.9	36.4	25.7	15.4	13.7	31.9	36.2	22.9	34.5	32.9	27.6	49.7	46.9	23.8	27.1	31.7	8.4	0.8	1.2	1.6	0.7	3.6	0.9	5.3	3.4	0.9	0.6	4.1	3.5	0.7	2.5	0.9	1.1	6.5	1.7	9.5	17.7	13.6	10.9	9.8	9.5	8.6	7.6	8.5	5.0	10.5	8.3	18.2	3.2	5.1	3.6	8.7	34.0	17.3	4.3	15.4	8.9	27.4	9.1	3.5	10.0	7.0	9.2	14.6	1.7	12.7	22.0	1.9	8.7	36.7	6.9	10.0	13.9	6.6	17.2	8.0	7.1	10.8	19.6	19.4	12.0	0.0	9.6	10.0	9.5	9.4	8.4	10.5	16.1	6.1	5.0	11.5	8.8	6.8	7.4	10.6	2.8	4.0	10.1	4.1	3.5	2.2	13.8	12.2	10.9	24.9	19.4	22.4	12.4	4.9	70.2	6.6	9.7	15.8	50.9	16.1	8.7	24.3	1.4	25.8	2.7	7.8	14.8
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1300.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 18.8;Gastric mucus-secreting cells: 20.4;Macrophages: 10.7;Smooth muscle cells: 23.6;Squamous epithelial cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"dendritic cells: 18.7;monocytes: 12.5;T-cells: 9.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	71.5	29.7	627.6	33.6	916.1	7.1	59.4	827.6	1054.5	73.6	462.6	160.9	54.5	106.6	41.7	58.7	102.7	33.1	470.5	645.7	709.8	56.3	10.4	63.1	21.3	871.6	808.2	39.1	39.9	65.3	41.3	42.9	853.0	70.2	91.1	34.9	47.7	89.4	316.2	68.6	78.4	100.9	739.9	30.3	82.2	14.4	822.1	23.2	37.2	248.2	27.3	118.7	69.7	1300.9	78.0	13.6	10.8	76.3	6.8	3.0	15.0	44.7	48.4	36.7	24.8	37.2	103.4	1.1	7.7	44.4	13.9	112.1	74.7	4.0	22.4	0.6	43.9	64.5	57.0	34.3	43.1	3.5	94.0	1.2	12.6	13.9	12.8	63.5	25.3	64.8	4.7	1.5	2.9	99.0	5.6	4.9	14.0	50.8	80.0	0.3	1.0	0.7	105.3	1.4	24.8	12.7	15.6	8.4	99.3	7.6	104.0	19.9	41.1	1.5	72.5	48.8	49.5	1.1	1.6	0.3	5.3	0.6	10.9	0.0	10.4	0.0	9.1	12.5	3.3	0.2	8.0	6.8	7.6	0.3	7.4	6.9	0.5	0.8	7.2	18.7	7.4	4.5	627.6	916.1	827.6	1054.5	645.7	709.8	871.6	808.2	853.0	739.9	822.1	1300.9	0.3	3.2	0.5	0.0	3.3	0.0	0.2	0.1	18.8	0.0	0.6	0.3	1.0	0.0	2.5	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.3	0.4	0.2	2.7	0.0	2.1	0.0	0.0	0.0	7.3	20.4	0.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	10.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	3.9	0.4	0.9	0.0	5.3	0.0	0.0	0.6	23.6	0.1	0.0	32.7	0.6	0.0	5.3	0.1	0.4	0.3
DLGAP4	"DAP4, KIAA0964, SAPAP4"	ENSG00000080845	"DLG associated protein 4"	Q9Y2H0	20	36306336-36528637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 213.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 212.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054105, HPA056378"	Approved		Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Focal adhesion sites"	"HPA054105: AB_2682381, HPA056378: "	"unprognostic (1.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-2)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (1.23e-1)"	"prognostic favorable (9.88e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	55.4	47.5	39.0	23.5	31.4	7.5	40.3	2.8	45.9	51.7	2.6	71.4	21.2	64.5	12.5	31.7	45.2	26.4	58.4	39.3	12.3	34.3	37.3	60.5	16.6	5.4	18.1	48.4	47.8	13.8	36.4	26.5	10.5	44.7	15.0	25.4	37.8	30.6	130.8	86.8	37.1	42.5	2.8	32.9	36.5	29.3	29.1	14.7	43.3	45.9	14.8	56.2	46.6	20.6	49.9	44.2	53.0	44.1	49.0	79.9	53.2	73.2	66.5	70.0	48.2	67.4	30.9	14.0	38.5	103.3	61.9	46.7	14.3	75.1	51.8	22.5	5.2	31.8	22.7	46.2	70.9	12.9	26.5	52.9	57.0	83.1	57.6	54.2	69.7	19.5	22.5	37.2	53.6	37.0	26.3	49.0	23.2	36.2	93.4	26.1	14.0	19.4	33.0	24.3	34.8	47.9	48.0	96.0	60.0	53.7	55.3	22.3	71.2	212.1	64.6	92.6	40.9	12.7	9.8	15.1	84.9	16.2	85.4	2.7	16.5	26.9	15.0	17.3	11.9	19.5	13.5	10.7	14.5	20.8	10.1	8.1	23.6	9.6	17.9	17.4	11.9	12.6	39.0	31.4	2.8	45.9	39.3	12.3	5.4	18.1	10.5	2.8	29.1	20.6	30.4	16.0	20.5	34.0	25.2	66.4	53.8	30.6	9.1	34.9	30.2	21.0	27.9	22.8	22.9	12.9	8.4	23.1	23.7	27.2	7.9	53.0	69.9	25.9	47.7	36.6	63.3	4.4	77.9	55.7	52.3	40.1	23.4	29.4	12.6	35.7	27.8	17.5	27.2	74.0	93.4	35.0	20.3	22.4	54.4	213.4	29.8	23.9	10.6	37.5	47.5	38.7	21.6	81.4	13.2	84.4	25.0	26.4	8.9	72.9	25.8	20.4	28.3	29.5	72.3	28.8	51.0	13.7	30.3	13.2	71.7	55.1	20.7	29.8	20.6	52.3
EDNRA	"ET-A, ETA-R, hET-AR"	ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 113.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	14.0	5.5	2.1	3.3	2.8	0.0	8.3	2.7	4.2	57.0	2.1	3.2	3.4	44.7	23.3	4.4	18.4	12.7	26.0	2.2	2.2	4.2	3.1	22.7	3.8	2.9	3.1	37.5	1.1	3.4	2.8	12.1	2.9	30.7	3.4	0.3	6.4	113.9	4.0	4.6	2.9	45.1	2.5	8.4	5.4	6.2	2.9	4.9	6.8	5.5	2.6	11.8	24.0	3.0	0.0	1.2	5.2	0.0	9.4	18.2	0.0	2.9	3.8	0.4	0.1	0.2	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.7	0.2	0.0	1.9	0.0	2.8	0.0	9.3	0.0	0.0	6.9	0.6	0.5	0.0	3.4	0.0	0.0	0.0	1.4	22.7	0.3	0.0	0.1	1.5	0.0	1.1	0.0	0.9	0.1	1.3	1.0	0.0	16.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.7	0.0	0.0	1.3	0.4	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	2.7	4.2	2.2	2.2	2.9	3.1	2.9	2.5	2.9	3.0	7.7	3.2	5.3	1.0	0.0	3.1	0.8	1.7	27.3	0.1	0.8	5.2	24.9	0.0	4.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	2.9	3.4	117.1	8.0	0.0	0.0	5.3	0.0	0.1	15.9	0.0	2.7	0.0	14.3	0.0	0.0	0.6	0.0	22.5	0.0	0.0	0.0	3.9	3.5	43.8	0.8	3.6	9.4	0.0	0.1	0.0	2.0	1.0	0.2	0.0	68.1	0.0	1.4	0.0	0.5	0.0	0.5	52.6	0.6	108.6	0.7	0.7	7.1	2.7	0.1	0.9	0.3	0.0	0.4
EHBP1L1	"DKFZp762C186, TANGERIN"	ENSG00000173442	"EH domain binding protein 1 like 1"	Q8N3D4	11	65576046-65592650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 255.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 79.1;Kupffer cells: 79.7;Macrophages: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039479, HPA073476"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		110000		"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Plasma membrane"		"HPA039479: AB_10795678, HPA073476: "	"unprognostic (1.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.10e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.10e-1)"	27.2	9.9	7.5	51.9	6.2	59.7	21.5	5.9	9.4	35.9	7.3	108.1	26.0	56.1	5.7	45.4	48.0	18.0	45.6	7.1	6.3	17.7	10.8	39.6	30.7	9.8	8.1	19.6	8.1	4.1	9.8	16.3	7.7	45.2	12.2	0.4	22.9	39.5	255.7	22.6	46.6	32.8	8.0	73.3	41.0	7.3	9.4	14.5	13.0	70.7	16.6	71.3	40.8	9.0	40.6	41.0	1.3	21.8	10.5	26.4	8.2	31.4	22.9	14.8	7.8	13.7	34.9	14.0	52.4	45.8	41.2	55.9	7.6	29.7	3.4	39.3	1.2	32.4	51.0	12.0	10.0	7.1	30.1	22.7	19.8	37.2	6.8	26.9	15.2	20.8	50.5	55.9	13.8	34.5	12.4	27.5	1.8	15.1	34.8	33.6	0.2	46.8	13.7	20.0	0.9	17.2	17.4	15.2	32.9	3.0	21.9	33.7	26.3	40.3	42.9	57.3	0.6	98.5	66.6	7.3	60.2	18.8	23.9	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	7.5	6.2	5.9	9.4	7.1	6.3	9.8	8.1	7.7	8.0	9.4	9.0	33.1	0.0	6.9	6.2	23.9	10.1	8.5	2.9	15.9	1.4	12.2	14.2	22.0	7.2	7.4	1.8	0.0	3.4	27.3	79.1	0.0	3.6	0.2	11.9	12.2	26.0	4.2	61.6	4.4	5.1	1.4	13.8	61.2	14.2	2.5	5.3	18.9	5.7	32.6	0.0	2.2	16.3	2.0	79.7	33.9	1.7	11.5	67.6	7.2	15.0	49.1	0.7	20.6	1.5	1.3	27.8	53.0	38.0	19.5	11.6	19.5	0.4	8.6	1.1	26.3	27.3	30.7	2.7	5.9	15.3	14.8	2.6	23.2	23.0	21.9	17.0
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	108.0	77.2	49.8	85.1	52.4	43.7	91.8	51.7	50.6	151.6	55.0	398.2	66.4	359.1	81.8	115.5	164.2	88.0	175.9	47.4	50.7	78.8	65.9	107.9	72.4	51.8	50.6	101.0	89.3	73.2	47.1	98.8	50.9	182.7	116.8	28.3	69.5	412.2	90.8	61.5	117.4	364.7	51.1	95.5	149.7	26.5	53.7	45.8	72.0	92.0	70.5	226.7	118.8	51.9	127.8	94.4	148.9	51.8	224.8	159.4	67.2	182.2	360.0	211.9	256.0	102.7	145.7	47.0	47.0	304.1	206.9	99.5	84.4	155.6	213.0	83.5	74.3	69.1	84.9	82.8	150.8	55.9	74.7	153.2	72.8	143.8	108.9	217.7	206.9	40.5	63.7	55.0	282.8	97.1	49.4	97.4	94.3	107.5	110.8	51.0	77.8	50.5	160.3	100.8	25.6	57.4	86.0	118.4	103.6	144.0	82.2	62.2	238.8	263.9	118.0	111.1	90.7	38.9	25.9	67.1	195.6	82.8	125.3	314.9	260.0	417.6	127.3	258.1	124.9	96.9	114.4	122.3	242.7	92.9	70.2	88.5	165.5	257.8	254.8	98.5	142.8	402.8	49.8	52.4	51.7	50.6	47.4	50.7	51.8	50.6	50.9	51.1	53.7	51.9	79.5	44.8	17.9	24.2	33.6	50.5	73.7	100.6	24.5	21.5	43.1	68.2	0.5	70.1	49.7	57.0	8.4	119.8	46.0	71.9	58.7	136.1	64.6	33.2	78.1	69.4	37.9	53.7	14.6	125.0	177.7	83.2	50.4	52.5	30.4	41.6	76.4	31.4	127.4	8.4	17.1	50.1	69.2	51.5	97.7	143.7	71.4	115.9	85.4	30.9	143.0	54.3	77.2	15.6	15.3	117.1	60.0	147.4	35.1	42.0	74.5	98.6	31.0	32.9	157.8	53.3	165.8	31.7	17.1	32.3	43.2	110.0	49.3	65.0	50.1	43.9
IQCJ-SCHIP1		ENSG00000283154	"IQCJ-SCHIP1 readthrough"	B3KU38	3	158962235-159897366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 165.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 7.3;Basal squamous epithelial cells: 12.5;Bipolar cells: 11.5;Excitatory neurons: 11.3"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA003243, HPA003445"	Approved		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA003243: AB_1079877, HPA003445: AB_1079875"																		22.0	5.1	82.3	9.7	90.6	2.2	15.4	84.9	165.9	9.2	56.6	49.8	4.5	19.6	6.3	15.4	18.2	12.5	57.2	83.9	73.9	17.8	14.3	19.6	2.2	93.5	88.0	4.4	2.7	1.1	7.3	23.6	92.0	17.7	6.8	14.2	6.5	20.4	27.6	5.7	12.8	25.9	81.5	4.3	18.3	4.7	87.2	2.5	5.7	3.2	1.8	35.8	10.8	110.5	87.9	14.8	28.9	34.4	6.6	6.3	25.1	73.6	17.3	59.4	40.5	55.6	20.9	4.4	46.4	24.6	22.6	34.8	11.3	24.9	48.5	72.7	27.6	0.1	31.2	2.8	7.7	4.2	0.5	6.5	20.8	26.5	31.1	49.3	44.5	4.9	0.0	0.3	27.7	3.9	0.3	0.0	24.2	7.0	31.9	10.2	58.4	0.0	57.6	4.7	5.8	26.8	39.8	16.7	21.8	32.9	9.8	0.8	37.6	34.0	47.5	22.9	101.5	0.3	0.5	0.4	19.1	12.4	92.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.3	90.6	84.9	165.9	83.9	73.9	93.5	88.0	92.0	81.5	87.2	110.5	4.7	6.4	0.0	1.0	0.1	1.5	7.3	0.8	12.5	11.5	0.3	0.9	0.6	0.0	1.4	1.8	6.2	0.0	0.1	0.3	0.0	0.9	2.0	2.1	0.8	5.7	0.0	0.0	11.3	0.6	0.0	3.1	0.0	2.3	2.5	0.0	1.8	0.6	0.0	0.0	4.7	0.2	0.0	0.3	1.2	0.6	0.3	1.2	0.0	0.0	0.6	0.5	0.0	0.0	0.6	1.2	0.0	1.2	0.0	1.3	0.0	4.2	2.4	0.6	0.0	2.5	5.4	0.1	0.4	3.5	0.9	0.0	0.5	0.0	0.2	1.6
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627587-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 322.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006979	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	44.2	21.0	11.3	49.2	9.0	86.8	34.0	3.8	11.0	34.1	23.0	63.2	35.9	64.3	15.7	58.2	32.1	39.4	69.7	11.7	10.8	51.7	48.9	61.7	45.4	7.3	6.9	16.0	21.2	55.1	14.8	41.4	7.0	40.9	40.3	6.4	38.0	31.2	111.0	23.7	35.9	58.8	5.9	45.7	49.6	5.4	9.4	43.5	37.8	50.7	52.6	69.4	43.4	7.3	99.1	50.1	17.5	45.9	25.4	55.6	77.7	67.4	62.3	37.8	37.2	19.2	64.6	8.4	27.4	108.8	81.2	80.9	54.0	100.4	80.2	322.6	34.7	78.0	55.1	54.8	58.5	104.2	71.0	23.9	205.8	88.2	216.0	50.6	59.8	54.0	58.4	77.8	79.5	47.8	60.5	79.5	29.6	73.3	45.1	87.9	125.3	80.1	122.0	141.8	46.3	24.0	33.5	76.2	92.2	37.6	42.9	129.2	99.4	42.4	41.1	49.5	77.0	15.8	14.3	53.2	63.4	102.7	51.0	78.5	104.1	248.4	74.8	97.5	55.1	55.9	89.0	77.3	84.1	60.1	46.1	52.2	326.2	46.9	168.9	73.1	76.7	61.4	11.3	9.0	3.8	11.0	11.7	10.8	7.3	6.9	7.0	5.9	9.4	7.3	236.4	487.2	307.3	35.6	249.6	307.0	391.9	166.0	113.3	46.4	128.6	86.2	160.3	127.2	269.9	172.9	37.5	111.2	347.1	319.5	52.8	229.7	7.9	368.3	88.2	213.0	190.5	62.4	175.9	333.0	359.2	109.1	159.0	426.3	241.0	56.9	122.0	149.1	175.8	21.9	237.5	168.3	79.3	271.2	721.3	7.9	29.8	398.9	167.2	57.1	365.0	25.1	213.1	111.1	12.5	389.6	220.6	23.3	146.6	430.5	152.8	49.5	286.1	6.0	78.9	147.3	182.9	10.1	27.4	179.3	243.1	25.3	288.5	158.3	150.0	588.4
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013382	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 171.2;intestine: 159.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 14.8"	"Region enhanced"	"Detected in some"		"spinal cord: 4.8"	HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	41.7	3.8	2.6	12.8	2.9	0.0	32.5	12.0	3.9	103.6	5.5	159.2	9.3	171.2	14.2	16.2	98.0	16.7	13.7	2.4	3.1	17.1	7.0	18.7	4.5	4.7	2.8	37.0	3.4	0.5	4.1	11.6	3.3	48.3	8.9	0.2	10.8	45.6	5.1	15.2	38.3	59.3	2.8	13.4	44.1	7.3	2.8	0.7	10.7	3.0	1.3	75.2	65.6	2.5	0.0	0.1	0.1	0.0	67.6	30.0	1.4	39.5	99.1	36.8	24.3	0.0	1.8	0.0	0.8	30.8	0.1	0.1	0.1	0.0	6.8	0.0	0.0	0.0	2.8	0.0	8.5	0.0	0.0	22.1	0.0	23.5	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.9	1.5	0.8	0.1	0.0	3.4	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.0	22.4	0.0	46.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	12.0	3.9	2.4	3.1	4.7	2.8	3.3	2.8	2.8	2.5	3.2	0.0	0.0	0.0	0.6	5.0	0.2	0.0	1.2	0.0	0.3	2.3	0.6	2.8	0.0	11.0	0.0	0.7	0.1	0.0	0.0	0.0	4.9	1.1	20.6	2.3	0.0	0.0	1.1	0.0	0.6	33.3	0.5	0.8	0.0	0.0	3.9	3.8	1.1	0.0	0.2	0.0	0.0	0.0	7.3	7.9	66.2	0.2	7.2	3.7	0.0	3.0	0.0	0.0	0.2	0.1	0.0	100.8	0.1	0.3	0.0	0.9	0.0	0.3	52.6	19.1	63.7	1.3	0.5	0.4	3.8	1.1	0.6	0.6	0.0	0.4
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	44.9	10.7	12.9	20.9	13.6	21.2	26.3	12.5	12.8	29.5	18.8	108.0	11.9	85.8	20.1	63.0	41.4	33.2	90.8	11.9	18.3	10.1	3.8	30.6	5.7	15.9	15.2	16.9	5.8	3.2	6.8	25.2	13.8	52.7	27.8	12.5	10.8	103.0	104.0	9.7	25.6	123.9	14.6	13.6	36.2	5.8	18.2	4.1	14.5	69.2	3.9	60.9	23.7	11.8	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	13.6	12.5	12.8	11.9	18.3	15.9	15.2	13.8	14.6	18.2	11.8	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703135-15857028	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3322.6;seminal vesicle: 1665.5;urinary bladder: 2048.3"	"Group enriched"	"Detected in many"	8	"Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6"	"Group enriched"	"Detected in many"	5	"prostate cancer: 173.2;stomach cancer: 125.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 39.8"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		23000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	172.9	38.6	5.0	109.1	17.2	0.2	78.4	5.5	14.5	372.3	11.1	3322.6	95.4	1074.6	219.7	759.7	606.1	250.6	74.8	5.3	5.2	27.9	9.2	108.9	9.5	9.0	7.0	144.0	10.7	2.8	11.6	68.2	7.1	762.7	293.2	0.4	83.3	1665.5	41.2	68.5	487.4	1053.2	5.8	46.0	832.5	60.9	7.2	2.9	46.0	34.6	5.3	2048.3	314.2	6.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.2	7.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	5.0	17.2	5.5	14.5	5.3	5.2	9.0	7.0	7.1	5.8	7.2	6.3	7.6	0.0	1.8	0.0	4.4	13.3	2.1	1.7	5.7	2.7	5.3	122.3	40.5	0.0	1.9	0.0	8.4	0.3	3.4	0.4	0.0	0.2	50.2	4.7	19.5	12.8	1.2	0.8	0.8	0.4	0.3	22.2	0.0	3.4	0.0	27.3	6.4	0.1	1.1	0.0	5.2	0.5	0.0	2.2	17.3	46.2	42.9	2.8	12.4	15.9	3.7	0.3	3.1	1.5	10.7	0.4	0.2	1669.7	2.4	5.6	0.1	0.2	2.5	1.9	624.5	4.3	964.6	3.1	8.8	3.5	18.6	0.0	5.7	34.7	0.4	2.6
NCS1	"FREQ, NCS-1"	ENSG00000107130	"Neuronal calcium sensor 1"	P62166	9	130172404-130237303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 272.0;intestine: 123.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.9;Horizontal cells: 112.7;Inhibitory neurons: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018587, HPA019713"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		10000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB018587: AB_649907, HPA019713: AB_1854404"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-3)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.61e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.65e-1)"	8.3	26.2	183.3	13.4	96.0	8.4	5.1	0.0	227.7	22.6	0.0	123.6	5.2	70.7	5.7	40.6	29.3	13.9	12.6	272.0	20.8	17.6	2.8	9.5	1.9	17.0	23.4	10.8	4.9	2.3	14.5	1.7	16.6	36.1	10.1	8.5	8.1	65.1	3.1	18.3	19.8	58.6	2.3	1.2	25.1	3.1	75.5	4.2	32.8	1.9	3.8	63.8	20.8	85.8	25.6	50.8	25.9	51.9	15.9	35.3	12.3	64.3	29.6	48.2	32.0	24.3	12.8	0.1	22.8	81.6	56.5	45.2	42.5	56.3	21.5	75.3	13.0	0.1	32.3	26.5	24.4	2.2	30.2	41.2	28.0	54.7	34.4	42.9	46.2	9.9	18.8	0.3	70.8	73.1	4.9	25.6	39.6	13.7	21.2	0.1	81.5	17.3	47.4	15.9	67.9	63.9	39.5	18.7	37.7	19.4	34.8	16.2	36.7	92.9	75.4	75.5	84.1	0.1	0.1	0.2	108.7	7.1	102.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.3	96.0	0.0	227.7	272.0	20.8	17.0	23.4	16.6	2.3	75.5	85.8	0.5	0.0	0.0	26.1	0.1	9.7	10.5	16.6	15.4	7.7	3.0	10.0	2.9	1.5	6.3	11.0	4.2	0.1	5.3	0.8	5.9	7.9	0.4	27.8	10.5	1.0	1.2	14.7	40.9	2.9	1.6	9.1	1.1	12.4	3.8	4.4	0.7	0.5	3.7	112.7	42.5	1.0	0.0	0.6	5.8	0.9	1.2	2.5	5.4	2.8	9.8	19.2	0.0	8.0	7.8	5.3	0.1	1.5	1.3	11.0	0.2	17.3	9.7	4.3	0.0	4.2	19.0	0.0	1.9	6.0	7.0	0.5	2.6	1.2	0.5	3.3
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137718	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 277.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 459.8;Late spermatids: 516.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol		No	No		1900000	"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018257: AB_10960391, HPA056484: AB_2683147"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.55e-4)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	35.0	11.5	41.6	41.5	39.3	14.4	23.5	13.8	49.9	26.3	61.7	43.8	48.8	55.5	5.6	67.1	34.9	34.1	128.6	60.4	65.0	44.6	4.7	19.1	32.5	30.7	50.9	19.1	15.9	15.2	29.9	15.5	58.0	35.6	30.7	277.0	39.8	62.0	70.4	40.3	59.6	44.1	8.3	19.1	36.8	141.1	47.0	29.7	38.5	21.0	21.2	64.7	42.8	31.7	314.8	420.2	25.9	0.6	26.8	56.9	336.9	187.2	66.6	186.2	222.8	444.5	320.4	37.0	147.8	134.9	174.9	243.0	141.7	292.3	173.1	102.1	111.0	132.0	189.1	24.2	65.2	53.7	203.4	27.0	61.2	190.0	96.0	273.7	367.8	153.7	37.0	1.3	195.7	239.8	182.5	44.4	42.9	133.9	149.3	138.8	46.9	150.1	185.7	115.9	69.5	64.7	133.7	111.0	172.0	307.8	93.7	80.3	449.2	124.6	65.3	380.5	199.3	195.4	200.1	135.7	331.0	98.0	78.5	30.8	8.5	2.9	26.8	4.2	21.2	13.7	26.2	25.0	14.5	15.3	9.6	15.4	1.3	26.7	1.6	22.5	37.6	16.5	41.6	39.3	13.8	49.9	60.4	65.0	30.7	50.9	58.0	8.3	47.0	31.7	30.5	3.2	7.0	128.6	14.8	28.7	58.5	96.8	14.8	40.4	10.3	7.7	147.4	8.6	57.9	64.4	54.2	7.8	16.3	72.6	43.0	115.7	459.8	41.2	9.0	36.0	37.2	10.3	49.4	10.8	205.8	25.9	35.7	63.8	55.9	25.8	14.6	0.7	33.9	42.1	25.9	23.1	124.1	7.6	31.4	516.3	7.5	14.3	19.6	15.0	15.4	113.1	16.5	16.1	6.7	116.8	57.2	6.8	14.2	80.9	53.2	5.9	62.6	133.4	13.1	43.2	34.6	149.4	3.5	25.1	22.6	26.5	28.8	11.2	28.9	64.2
PRKG1	"PGK, PKG, PKG1, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase cGMP-dependent 1"	Q13976	10	50990888-52298423	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 778.3;Excitatory neurons: 244.9;Inhibitory neurons: 473.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	49	"granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.3;BJ hTERT+: 19.2;fHDF/TERT166: 16.1;U-138 MG: 11.2;U-87 MG: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	7.0	8.3	6.4	2.7	7.2	0.6	3.1	1.4	6.9	10.3	12.4	5.5	2.4	10.3	3.5	5.2	5.2	7.0	14.1	6.6	10.7	3.8	1.7	6.8	1.2	5.1	4.6	4.2	1.7	9.6	1.3	10.1	3.2	6.4	5.3	3.6	4.0	8.1	25.8	1.0	3.4	14.6	5.3	2.5	3.3	1.8	12.2	1.5	7.0	36.1	0.9	5.4	4.2	2.7	0.1	0.2	1.7	14.3	6.5	6.0	0.1	5.4	19.2	2.1	2.6	0.1	0.9	0.3	0.0	16.1	2.0	0.1	0.0	0.1	1.7	0.0	5.0	1.0	0.3	0.0	5.5	0.0	0.1	8.1	0.1	4.8	0.1	0.6	0.0	0.0	0.0	0.1	5.3	0.1	0.0	0.0	4.1	0.0	2.5	0.0	3.9	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	2.0	0.1	0.0	0.0	11.2	1.9	5.9	3.7	1.5	0.8	0.0	10.0	0.0	2.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.4	7.2	1.4	6.9	6.6	10.7	5.1	4.6	3.2	5.3	12.2	2.7	10.5	16.0	10.8	778.3	0.3	0.9	1.7	0.0	7.4	5.9	2.8	9.4	31.4	0.0	0.0	3.7	0.0	1.0	0.3	2.9	0.0	2.4	56.0	0.4	14.7	7.1	0.0	3.4	244.9	3.6	1.2	24.2	0.5	0.5	4.5	0.1	5.0	0.0	0.4	0.0	473.0	4.2	0.0	0.0	2.2	53.0	32.6	5.3	3.6	188.3	0.0	23.6	0.0	24.6	8.0	4.8	14.1	39.5	0.1	0.5	3.2	0.2	0.9	1.3	39.5	3.9	69.9	0.9	0.9	1.6	0.6	2.2	0.2	7.9	3.6	1.0
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.6;intestine: 21.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 327.5;Late spermatids: 920.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5"	"Group enriched"	"Detected in many"	5	"medulla oblongata: 51.9;pons: 53.6;white matter: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 367.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.4;pons and medulla: 35.1"	"Region enriched"	"Detected in many"	8	"spinal cord: 256.8"	"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	3.1	14.5	0.9	7.5	1.1	0.0	1.8	0.3	1.8	3.3	0.4	21.0	4.7	0.8	0.1	0.5	3.1	0.6	1.2	0.9	2.2	0.9	0.1	0.9	0.2	51.9	8.0	0.7	1.3	0.1	2.9	0.3	53.6	2.3	2.1	1.5	0.5	1.5	0.4	1.1	8.9	2.0	7.8	1.2	5.2	13.2	0.9	0.1	0.5	0.2	0.1	1.5	8.3	15.7	0.0	0.7	0.0	367.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.7	1.6	0.4	1.3	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.7	0.0	0.2	2.0	0.0	2.2	0.4	0.0	1.6	86.6	1.5	0.2	0.8	0.0	0.0	1.7	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	1.8	0.9	2.2	51.9	8.0	53.6	7.8	0.9	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.3	0.8	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	327.5	0.5	0.1	1.4	92.3	0.0	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.2	0.1	1.0	0.0	0.0	0.9	920.2	5.9	0.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.8	0.1	38.1	0.0	0.1	14.1	96.1	19.4	0.3	0.4	0.0	0.1	0.0	0.5	0.2
RASL12	RIS	ENSG00000103710	"RAS like family 12"	Q9NYN1	15	65053337-65076690	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (6.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (1.76e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.17e-4)"	27.9	3.9	32.9	5.1	36.8	0.0	15.7	30.8	24.4	49.8	8.5	35.6	3.6	61.6	27.9	19.2	54.7	13.2	53.4	26.0	38.4	6.9	1.1	38.4	3.3	39.4	57.4	16.5	2.4	1.8	7.0	17.0	38.0	52.5	6.7	3.3	8.0	76.4	37.1	12.1	9.4	33.0	38.8	9.6	7.7	15.6	66.1	0.9	8.4	20.6	1.7	40.2	33.5	32.6	0.1	0.1	0.2	0.0	0.6	5.0	0.2	0.0	0.5	0.0	0.0	14.5	0.1	0.0	22.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	36.8	30.8	24.4	26.0	38.4	39.4	57.4	38.0	38.8	66.1	32.6	7.4	0.0	0.0	22.5	0.0	1.5	3.9	0.0	0.0	0.3	2.0	5.6	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.7	0.3	12.6	3.6	0.0	0.0	0.1	0.0	0.1	15.2	0.5	0.5	0.0	12.3	1.4	0.1	0.3	0.0	0.1	0.0	2.0	0.0	1.3	3.9	13.1	0.2	0.0	2.8	0.0	17.9	0.0	0.0	0.0	0.1	0.0	57.9	0.0	0.4	0.5	0.0	0.0	0.8	98.6	0.9	55.7	0.7	1.1	0.4	0.1	0.3	0.2	0.4	0.2	0.1
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 subunit beta"	Q86UW2	15	65045387-65053397	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 41.8;intestine: 107.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.7	1.1	5.8	3.5	5.5	0.8	0.3	4.0	3.9	41.8	0.0	41.9	86.9	3.0	0.3	2.4	3.6	2.8	2.3	3.8	6.5	19.5	2.2	6.1	0.6	7.3	10.9	1.1	0.3	0.0	0.4	0.6	7.7	2.7	29.4	0.7	1.0	0.6	1.0	0.8	107.1	1.7	6.5	0.8	0.8	9.6	11.8	0.0	0.7	0.0	0.0	1.5	0.9	4.2	0.0	1.5	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	18.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.1	0.4	0.4	0.1	0.4	0.0	0.0	0.9	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	4.0	3.9	3.8	6.5	7.3	10.9	7.7	6.5	11.8	4.2	0.0	0.0	1.1	0.3	1.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.1	0.0	354.6	13.7	0.0	60.8	10.4	0.2	1.2	1.8	2.7	0.0	0.0	0.0	0.5	0.0	1.9	4.5	0.0	0.4	1.8	0.1	0.0	0.0	23.0	0.0	0.3	0.0	14.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.1	0.0	0.0	0.0	721.4	73.3	15.6	0.0	6.6	1.0	0.4	27.9	0.5	0.0	0.0	0.1	0.6	0.1	45.8	0.0
STING1	"ERIS, FLJ38577, MITA, MPYS, NET23, STING, TMEM173"	ENSG00000184584	"Stimulator of interferon response cGAMP interactor 1"	Q86WV6	5	139475533-139482935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 25.3;Cardiomyocytes: 27.7;dendritic cells: 17.0;Hofbauer cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.4;EFO-21: 83.8;HDLM-2: 200.5;THP-1: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	38.9	9.3	4.6	18.4	5.0	16.9	26.2	4.4	5.4	32.6	12.8	16.6	6.7	25.0	6.8	21.5	36.2	11.9	35.7	4.3	4.9	17.3	5.5	48.1	15.0	5.5	4.9	21.9	5.4	3.3	11.8	12.9	5.1	20.7	11.6	0.3	24.5	15.5	7.5	15.5	19.0	18.7	5.3	37.8	11.6	3.1	6.0	12.4	20.2	8.5	27.1	21.7	28.4	4.8	2.9	0.7	0.2	0.0	4.0	12.0	0.2	15.3	64.4	7.6	24.4	0.0	18.8	0.0	83.8	49.0	1.9	10.8	0.4	22.9	4.8	200.5	3.3	13.5	6.6	0.8	7.5	4.1	0.8	16.2	1.2	4.6	5.7	12.8	27.8	1.4	3.9	58.3	33.6	0.0	2.2	24.1	0.1	0.8	4.7	0.7	6.1	18.0	9.4	7.0	5.8	0.0	6.5	5.3	16.0	0.6	0.7	73.3	17.2	1.9	1.3	6.8	5.6	0.0	20.0	0.1	0.3	56.2	11.3	16.6	60.9	0.1	56.9	40.0	29.3	0.6	57.4	47.8	55.6	0.3	40.3	35.0	5.0	90.6	17.5	19.2	65.3	60.6	4.6	5.0	4.4	5.4	4.3	4.9	5.5	4.9	5.1	5.3	6.0	4.8	25.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.8	5.8	0.0	0.0	0.0
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199370-117207464	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 9628.1;intestine: 11712.2"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 279.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 41.6;non-classical monocyte: 63.1"	"Lineage enriched"	"Detected in many"	12	"monocytes: 63.1"	"Cell line enhanced"	"Detected in all"		"BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		6300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	2235.7	512.7	118.5	963.9	144.4	12.1	1680.5	126.1	215.9	3611.3	172.5	11712.2	451.2	9628.1	693.9	1954.6	4610.6	893.8	1583.5	119.6	120.4	774.5	302.8	1258.6	245.5	137.0	127.0	1643.4	218.6	65.3	254.6	348.0	129.2	4624.1	1154.6	22.9	461.8	6383.6	356.4	619.8	1948.4	7108.7	127.2	532.0	3148.4	202.5	138.2	52.2	723.2	152.4	59.9	5521.7	2331.2	130.0	17.5	5.5	293.3	8.2	140.0	123.8	226.7	1913.4	788.1	1641.8	609.0	1531.4	28.4	3.2	2145.6	2094.4	1.7	46.1	4.4	16.8	543.3	6.8	4.4	5.0	66.9	130.2	708.7	1.7	5.2	304.6	57.5	267.1	36.1	1499.7	3.3	4.5	3.3	6.7	1377.1	4.5	1.7	15.8	84.6	18.8	2.1	2.7	23.1	12.0	4.4	25.8	1.9	9.6	29.9	11.0	1.5	807.6	9.2	5.1	182.0	1598.8	276.9	14.4	86.6	8.9	8.8	21.7	9.1	7.7	6.2	1.8	2.7	0.1	0.3	41.6	0.5	3.6	0.1	0.0	3.2	5.1	0.2	0.1	0.3	0.0	63.1	1.6	0.5	2.1	118.5	144.4	126.1	215.9	119.6	120.4	137.0	127.0	129.2	127.2	138.2	130.0	264.8	38.5	6.1	4.6	10.3	63.9	453.4	248.6	10.8	9.9	74.0	2508.6	1.3	4.3	22.5	40.5	18.8	57.0	8.6	3.1	0.0	577.8	3.3	14.6	455.5	260.3	3.0	2.7	4.5	74.5	35.3	464.4	41.3	12.8	1.3	32.4	639.7	8.9	41.5	1.7	6.5	18.3	24.4	23.1	91.8	23.9	48.4	33.8	96.0	37.5	8.1	4.9	2.1	3.0	11.9	38.4	4.5	2306.4	3.2	414.0	12.1	2.2	23.0	9.9	2866.2	177.6	4563.9	6.0	13.7	8.6	60.9	32.2	15.1	8.3	3.1	62.0
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 100.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	65.5	17.0	4.8	22.7	5.1	1.0	52.8	4.6	6.9	119.0	4.4	264.4	14.5	265.6	12.4	38.2	143.2	14.4	48.5	4.6	4.7	26.6	9.7	54.7	4.8	5.6	4.6	78.6	8.2	8.6	8.2	19.7	5.0	87.6	23.9	0.7	21.0	80.8	13.1	28.5	61.7	106.1	4.7	33.0	78.5	10.2	5.1	1.4	26.8	10.5	4.9	171.1	73.6	4.4	13.3	16.6	25.9	0.0	25.4	46.1	0.3	70.8	64.8	43.6	30.1	6.6	4.5	0.0	65.1	62.3	29.1	20.6	6.0	13.3	56.4	0.1	0.3	17.5	29.1	3.7	67.4	0.0	19.8	31.1	18.7	27.5	16.3	100.0	29.2	0.0	1.5	0.0	51.9	0.1	0.0	1.6	1.4	1.4	16.2	0.0	30.9	0.1	12.5	6.6	0.0	19.0	27.5	0.2	14.1	20.9	0.1	1.7	82.4	79.8	19.2	21.4	31.8	0.1	0.1	0.2	34.9	0.8	49.6	9.5	0.0	0.1	0.2	0.0	0.3	0.9	0.9	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.3	1.6	1.3	4.8	5.1	4.6	6.9	4.6	4.7	5.6	4.6	5.0	4.7	5.1	4.4	76.9	6.4	4.8	0.0	0.4	12.6	23.9	34.8	14.8	0.4	4.1	71.5	13.4	5.7	3.4	7.3	0.0	1.2	1.5	1.8	7.9	33.3	1.2	3.6	76.2	48.8	0.0	11.0	0.1	22.5	1.2	64.4	4.6	2.9	6.3	35.3	29.6	0.3	14.6	0.0	0.1	4.7	0.0	0.3	15.4	3.3	92.2	9.3	40.9	2.8	4.2	7.0	0.0	3.5	0.1	28.4	2.2	179.0	1.4	20.1	13.3	19.7	1.1	1.4	223.5	17.4	176.0	1.5	3.6	1.9	11.2	1.8	2.6	20.3	5.3	4.6
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103002	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1297.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 2111.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		370000000	"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	324.1	109.9	24.7	186.3	26.3	33.8	269.0	42.1	40.4	342.4	23.4	255.0	64.6	455.0	10.6	401.8	310.0	144.8	189.6	23.2	27.0	168.1	54.1	374.1	78.2	30.7	28.7	293.8	77.9	23.6	93.4	170.7	31.9	212.1	39.2	3.6	267.2	140.4	50.3	241.4	153.8	190.4	29.1	244.1	201.4	66.2	36.6	32.4	119.4	19.3	68.5	287.5	333.8	27.8	614.5	275.2	194.7	190.9	701.3	728.2	725.6	1082.9	470.3	356.4	357.7	325.5	473.5	31.1	724.2	492.9	383.9	331.6	72.9	386.7	141.6	503.8	138.8	305.4	270.2	232.3	357.0	52.3	728.3	715.2	94.0	327.6	331.1	353.2	427.2	115.7	46.2	217.9	360.8	290.2	152.4	233.0	227.1	461.2	380.4	201.4	413.2	143.4	87.3	387.9	75.3	315.3	670.4	155.5	298.8	90.6	5.3	60.8	1237.2	954.1	166.8	2111.0	875.3	82.4	167.3	142.5	651.4	144.5	337.0	130.8	81.4	5.9	96.0	93.9	71.4	59.6	69.0	84.3	96.6	53.0	18.6	47.2	82.1	75.2	50.4	76.8	151.0	158.4	24.7	26.3	42.1	40.4	23.2	27.0	30.7	28.7	31.9	29.1	36.6	27.8	389.4	400.6	156.6	9.4	148.6	431.1	1297.2	175.2	273.8	45.9	194.3	189.4	49.1	120.1	297.0	242.8	10.4	263.5	205.6	298.4	13.7	717.1	67.3	159.0	506.6	425.5	94.0	33.4	23.8	571.6	852.9	345.1	303.7	305.0	249.6	170.8	288.8	4.2	336.8	5.0	19.0	215.8	101.7	112.0	368.8	54.8	173.1	433.2	142.3	26.2	249.5	7.5	132.8	13.6	48.5	1017.2	258.8	547.2	310.9	900.2	61.2	29.0	133.1	11.7	335.2	170.0	516.6	29.5	10.1	328.2	343.8	568.9	192.0	222.3	162.7	1025.0
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 339.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 568.3;hTERT-RPE1: 547.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		750000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	85.8	19.1	9.9	52.2	10.6	41.5	45.3	8.4	11.3	73.9	33.4	180.3	35.3	167.6	45.9	92.2	75.9	69.4	132.2	10.5	11.3	37.2	24.1	68.7	18.7	10.3	10.3	45.2	40.3	51.3	13.8	88.6	13.3	131.7	73.1	12.5	31.6	151.9	136.9	37.9	52.7	224.7	9.9	41.9	63.5	41.3	12.1	12.8	39.6	144.1	23.9	135.7	56.3	8.4	147.2	97.0	174.2	123.8	213.2	246.2	95.8	188.5	568.3	126.3	141.9	88.4	124.0	6.5	153.1	331.6	86.3	183.3	115.7	95.0	132.5	12.3	49.6	69.4	92.2	37.2	116.5	14.1	101.8	205.0	25.0	171.5	154.8	547.4	171.0	11.6	50.7	14.3	213.1	25.2	2.0	16.6	82.8	69.9	342.4	24.0	90.9	18.6	180.4	185.8	6.5	25.8	104.7	117.2	53.9	152.8	54.5	21.2	230.9	136.9	57.0	67.0	179.4	2.6	6.0	28.4	160.0	38.9	39.7	15.0	13.6	36.2	14.9	17.1	10.4	5.6	7.1	7.8	20.7	2.3	2.6	5.3	11.2	4.4	19.0	8.0	1.9	28.3	9.9	10.6	8.4	11.3	10.5	11.3	10.3	10.3	13.3	9.9	12.1	8.4	68.0	99.3	39.7	56.5	13.4	114.7	161.4	68.4	30.7	13.4	39.4	58.5	339.5	37.1	79.8	42.3	85.5	51.5	46.7	91.2	3.9	60.8	5.0	98.2	152.6	60.4	38.3	5.9	63.2	61.6	78.6	74.4	66.3	149.1	35.4	45.5	56.7	34.4	23.6	16.8	47.5	44.5	22.4	31.9	51.0	7.5	50.1	77.9	26.6	55.3	44.7	9.7	61.8	18.6	4.6	125.5	48.3	76.8	8.0	100.1	13.7	14.8	37.7	34.5	105.2	49.6	179.9	18.6	13.7	45.6	93.1	39.7	18.3	44.5	48.7	94.8